Maculaser
Maculaser: Develops personalized, temperature-controlled retinal laser therapy to prevent progression of eye diseases. HealthTech · Seed · Espoo, Finland.…
Develops personalized, temperature-controlled retinal laser therapy to prevent progression of eye diseases.
Preliminary profile · public data only
Startup24 listed Maculaser from public information on the company's own website; its founders have not claimed or verified the profile yet. The rating below is preliminary, based on public data only, and is an opinion — not investment advice. Founders can claim the profile, and anyone can report an error or request removal, on this page.
At a glance
- Category: HealthTech (Ophthalmic medical devices and retinal laser therapy)
- Stage: Seed
- Location: Espoo, Finland
Startup24 rating: 65/100
Maculaser is a seed-stage ophthalmic device company pursuing a differentiated, patented retinal laser approach for large and persistent disease needs.
About the rating
Every startup on Startup24 is scored on the same six criteria — team, market, product, advantages, risk and reputation — with the reasoning written out. Founders list for free; investors subscribe to see the full analysis.
Startup24 (startup-24.com) rates startups on real, verified data: founders list for free, investors subscribe to find them first. Operated by DOTOVO OÜ, Tallinn, Estonia.